These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 10791955)

  • 1. MIP-T3, a novel protein linking tumor necrosis factor receptor-associated factor 3 to the microtubule network.
    Ling L; Goeddel DV
    J Biol Chem; 2000 Aug; 275(31):23852-60. PubMed ID: 10791955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential requirements for tumor necrosis factor receptor-associated factor family proteins in CD40-mediated induction of NF-kappaB and Jun N-terminal kinase activation.
    Leo E; Welsh K; Matsuzawa S; Zapata JM; Kitada S; Mitchell RS; Ely KR; Reed JC
    J Biol Chem; 1999 Aug; 274(32):22414-22. PubMed ID: 10428814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD40-tumor necrosis factor receptor-associated factor (TRAF) interactions: regulation of CD40 signaling through multiple TRAF binding sites and TRAF hetero-oligomerization.
    Pullen SS; Miller HG; Everdeen DS; Dang TT; Crute JJ; Kehry MR
    Biochemistry; 1998 Aug; 37(34):11836-45. PubMed ID: 9718306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a new microtubule-interacting protein Mip-90.
    González M; Cambiazo V; Maccioni RB
    Eur J Cell Biol; 1995 Jun; 67(2):158-69. PubMed ID: 7664757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular basis for CD40 signaling mediated by TRAF3.
    Ni CZ; Welsh K; Leo E; Chiou CK; Wu H; Reed JC; Ely KR
    Proc Natl Acad Sci U S A; 2000 Sep; 97(19):10395-9. PubMed ID: 10984535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T3JAM, a novel protein that specifically interacts with TRAF3 and promotes the activation of JNK(1).
    Dadgostar H; Doyle SE; Shahangian A; Garcia DE; Cheng G
    FEBS Lett; 2003 Oct; 553(3):403-7. PubMed ID: 14572659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-affinity interactions of tumor necrosis factor receptor-associated factors (TRAFs) and CD40 require TRAF trimerization and CD40 multimerization.
    Pullen SS; Labadia ME; Ingraham RH; McWhirter SM; Everdeen DS; Alber T; Crute JJ; Kehry MR
    Biochemistry; 1999 Aug; 38(31):10168-77. PubMed ID: 10433725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD40 signaling through tumor necrosis factor receptor-associated factors (TRAFs). Binding site specificity and activation of downstream pathways by distinct TRAFs.
    Pullen SS; Dang TT; Crute JJ; Kehry MR
    J Biol Chem; 1999 May; 274(20):14246-54. PubMed ID: 10318845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TRAF3 forms heterotrimers with TRAF2 and modulates its ability to mediate NF-{kappa}B activation.
    He L; Grammer AC; Wu X; Lipsky PE
    J Biol Chem; 2004 Dec; 279(53):55855-65. PubMed ID: 15383523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An atypical tumor necrosis factor (TNF) receptor-associated factor-binding motif of B cell-activating factor belonging to the TNF family (BAFF) receptor mediates induction of the noncanonical NF-kappaB signaling pathway.
    Morrison MD; Reiley W; Zhang M; Sun SC
    J Biol Chem; 2005 Mar; 280(11):10018-24. PubMed ID: 15644327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MIP-T3 is a negative regulator of innate type I IFN response.
    Ng MH; Ho TH; Kok KH; Siu KL; Li J; Jin DY
    J Immunol; 2011 Dec; 187(12):6473-82. PubMed ID: 22079989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epstein-Barr virus-encoded LMP1 and CD40 mediate IL-6 production in epithelial cells via an NF-kappaB pathway involving TNF receptor-associated factors.
    Eliopoulos AG; Stack M; Dawson CW; Kaye KM; Hodgkin L; Sihota S; Rowe M; Young LS
    Oncogene; 1997 Jun; 14(24):2899-916. PubMed ID: 9205097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel RING finger protein interacts with the cytoplasmic domain of CD40.
    Hu HM; O'Rourke K; Boguski MS; Dixit VM
    J Biol Chem; 1994 Dec; 269(48):30069-72. PubMed ID: 7527023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular responses to murine CD40 in a mouse B cell line may be TRAF dependent or independent.
    Manning E; Pullen SS; Souza DJ; Kehry M; Noelle RJ
    Eur J Immunol; 2002 Jan; 32(1):39-49. PubMed ID: 11754002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assembly and regulation of the CD40 receptor complex in human B cells.
    Kuhné MR; Robbins M; Hambor JE; Mackey MF; Kosaka Y; Nishimura T; Gigley JP; Noelle RJ; Calderhead DM
    J Exp Med; 1997 Jul; 186(2):337-42. PubMed ID: 9221764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LMP1 protein from the Epstein-Barr virus is a structural CD40 decoy in B lymphocytes for binding to TRAF3.
    Wu S; Xie P; Welsh K; Li C; Ni CZ; Zhu X; Reed JC; Satterthwait AC; Bishop GA; Ely KR
    J Biol Chem; 2005 Sep; 280(39):33620-6. PubMed ID: 16009714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TRAF5, a novel tumor necrosis factor receptor-associated factor family protein, mediates CD40 signaling.
    Ishida TK; Tojo T; Aoki T; Kobayashi N; Ohishi T; Watanabe T; Yamamoto T; Inoue J
    Proc Natl Acad Sci U S A; 1996 Sep; 93(18):9437-42. PubMed ID: 8790348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteomic analysis reveals novel binding partners of MIP-T3 in human cells.
    Guo CW; Xiong S; Liu G; Wang YF; He QY; Zhang XE; Zhang ZP; Ge F; Kitazato K
    Proteomics; 2010 Jun; 10(12):2337-47. PubMed ID: 20391533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structurally distinct recognition motifs in lymphotoxin-beta receptor and CD40 for tumor necrosis factor receptor-associated factor (TRAF)-mediated signaling.
    Li C; Norris PS; Ni CZ; Havert ML; Chiong EM; Tran BR; Cabezas E; Reed JC; Satterthwait AC; Ware CF; Ely KR
    J Biol Chem; 2003 Dec; 278(50):50523-9. PubMed ID: 14517219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of TRAF6, a novel tumor necrosis factor receptor-associated factor protein that mediates signaling from an amino-terminal domain of the CD40 cytoplasmic region.
    Ishida T; Mizushima Si; Azuma S; Kobayashi N; Tojo T; Suzuki K; Aizawa S; Watanabe T; Mosialos G; Kieff E; Yamamoto T; Inoue J
    J Biol Chem; 1996 Nov; 271(46):28745-8. PubMed ID: 8910514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.